Shares of Energy Fuels surged +9.6% to $15.23 on August 21, snapping a three-month losing streak, after a major Japanese magnet maker — one of the world's largest manufacturers of rare earth permanent magnets outside China — cleared the company's terbium oxide for commercial use with no further testing required. The approval is the strongest validation yet of the Utah-based company's pivot from uranium miner to critical-minerals producer, but investors need to separate the strategic signal from the revenue reality.
A Rare Stamp of Approval Bypasses China's Chokehold. China controls over 90% of global terbium production and has heavily restricted exports.
Terbium improves heat resistance and performance in the neodymium magnets that power electric vehicles, robotics, aerospace systems, and defense equipment. By qualifying its White Mesa Mill output, Energy Fuels can now supply terbium oxide without further validation, streamlining its entry into a critical supply chain segment. That is a concrete competitive edge against other Western rare-earth hopefuls still stuck in testing phases.
The Revenue Picture Is Still Mostly Uranium — and Mostly Red Ink. Energy Fuels reported Q1 2026 revenue of $35.8 million, driven primarily by uranium sales, while narrowing its quarterly net loss to $10.8 million.
Q2 showed higher sales of $25.1 million but a wider net loss of $33.4 million as the $104 million White Mesa rare earth expansion ate into cash. Terbium oxide trades at roughly $5.5 million per tonne, a high-value product — but volumes are still at pilot scale, meaning near-term revenue contribution is minimal.
The Bigger Bet Hinges on Scale-Up and Acquisitions. The company plans to shift to commercial-scale dysprosium and terbium production in the second half of 2026.
Phase 2, however, is permit-driven and commissioning is not expected until late 2028 or early 2029.
A proposed acquisition of Australian Strategic Materials would extend the company downstream into higher-value metals and alloys, but multiple regulatory approvals remain pending.
Valuation Already Prices in the Dream. The stock trades at a price-to-sales ratio of 32.3×, above its historical median of 27.6×, while insiders have sold $12.2 million worth of stock against just $1 million in purchases over the past year. The Japanese qualification is a genuine milestone, but the gap between product approval and profitable production remains wide — and the market is already paying for a lot of future success.